What Peptides Are FDA Approved? The Complete List

Introduction#

While the peptide landscape is often discussed in the context of research compounds and compounding pharmacies, a significant number of peptides have navigated the FDA approval process and are available as prescription medications. These approved peptides represent molecules with robust clinical trial evidence supporting their safety and efficacy for specific medical indications.

This article provides a comprehensive list of FDA-approved peptide drugs, organized by therapeutic category. Understanding which peptides are approved -- and for what indications -- helps distinguish between legally prescribed treatments and the broader world of research peptides.

For information about which peptides have been banned from compounding, see our guide to FDA-banned peptides.

What "FDA Approved" Means for Peptides#

An FDA-approved peptide drug has completed the full regulatory approval process, which includes:

1. Preclinical testing: Laboratory and animal studies demonstrating the drug's safety and biological activity
2. Phase 1 clinical trials: Safety and dosing studies in a small number of human volunteers
3. Phase 2 clinical trials: Efficacy and side effect studies in patients with the target condition
4. Phase 3 clinical trials: Large-scale efficacy and safety trials comparing the drug to placebo or existing treatments
5. FDA review: Comprehensive evaluation of all submitted data by the FDA
6. Post-market surveillance: Ongoing safety monitoring after approval

This process typically takes 10-15 years and costs hundreds of millions to billions of dollars. It is the reason relatively few peptides achieve approval despite the large number that show promise in early research.

FDA-Approved Peptide Drugs by Category#

Weight Management and Metabolic Disease#

The GLP-1 receptor agonist class represents the most commercially successful category of peptide drugs, with semaglutide and tirzepatide becoming some of the highest-revenue pharmaceutical products globally.

Growth Hormone Related#

Tesamorelin is notable as the only FDA-approved GHRH analog, specifically approved for reducing visceral adipose tissue in HIV patients with lipodystrophy.

Reproductive Health#

GnRH agonists and antagonists represent one of the most established classes of peptide therapeutics, with applications spanning oncology, reproductive medicine, and endocrinology.

Sexual Health#

PT-141 is the only FDA-approved melanocortin receptor agonist for sexual dysfunction, making it distinct from most other approved peptide drugs in both its target and mechanism.

Bone and Calcium Metabolism#

Gastrointestinal#

Cardiovascular#

Other Approved Peptide Drugs#

Peptides in Late-Stage Clinical Trials#

Several peptides are in Phase 3 clinical trials and may receive FDA approval in the coming years:

These pipeline peptides represent the next wave of potential approvals, particularly in the metabolic disease space. For more on upcoming peptides, see our clinical trials 2026 article.

FDA-Approved vs. Research Peptides#

The difference in evidence quality between approved and unapproved peptides cannot be overstated. An FDA-approved peptide has been studied in thousands to tens of thousands of human subjects with rigorous safety monitoring. Many research peptides have never been formally studied in humans at all.

How to Access FDA-Approved Peptides#

FDA-approved peptide drugs are obtained through:

1. Prescription from a licensed healthcare provider: A physician, nurse practitioner, or physician assistant evaluates whether the peptide is medically appropriate
2. Dispensing from a licensed pharmacy: Retail, specialty, or mail-order pharmacies fill the prescription
3. Insurance coverage: Many approved peptides are covered by health insurance, though coverage varies by plan and indication

For peptide dosing information and calculations, use our dosing calculator. For understanding how long approved peptides take to produce effects, see our peptide timelines guide.

Key Takeaways#

1. Over 50 peptide drugs have received FDA approval across categories including metabolic disease, reproductive health, bone metabolism, and gastrointestinal disorders.

2. GLP-1 receptor agonists are the most commercially successful peptide drug class. Semaglutide and tirzepatide have become blockbuster medications for diabetes and obesity.

3. FDA approval requires extensive clinical evidence -- typically 10-15 years of development and Phase 1-3 clinical trials involving thousands of participants.

4. The gap between approved and research peptides is significant. Approved peptides have proven safety and efficacy; many research peptides have not been studied in humans.

5. Several promising peptides are in late-stage clinical trials and may receive approval in the coming years, particularly in the weight loss space.

6. Access to FDA-approved peptides requires a prescription from a licensed healthcare provider and dispensing through a licensed pharmacy.

Related Peptide Profiles#

Learn more about the peptides discussed in this article:

• Semaglutide Overview and Research Guide
• Semaglutide Dosing Protocols
• Semaglutide Side Effects and Safety
• Tirzepatide Overview and Research Guide
• Tirzepatide Dosing Protocols
• Tirzepatide Side Effects and Safety
• Gonadorelin Overview and Research Guide
• Gonadorelin Dosing Protocols
• Gonadorelin Side Effects and Safety
• Triptorelin Overview and Research Guide
• Triptorelin Dosing Protocols
• Triptorelin Side Effects and Safety
• Tesamorelin Overview and Research Guide
• Tesamorelin Dosing Protocols
• Tesamorelin Side Effects and Safety
• PT-141 Overview and Research Guide
• PT-141 Dosing Protocols
• PT-141 Side Effects and Safety